Orthofix Medical Inc., a Lewisville‑based medical‑device manufacturer, reported a third‑quarter loss of $6.1 million on Monday, according to the Associated Press via WTOP. The loss translated to 15 cents per share, while adjusted earnings—excluding non‑recurring costs and stock‑option expense—were 18 cents per share.
Revenue for the quarter totaled $207.9 million, with adjusted revenue at $207.8 million. Both figures fell short of the Street forecasts; three analysts surveyed by Zacks had expected $210.4 million in revenue.
Despite the short‑term shortfall, Orthofix provided a forward‑looking outlook that projects full‑year revenue in the range of $825 million to $830 million. This guidance suggests the company anticipates a rebound and continued contribution to the local economy.
Local residents and business leaders view Orthofix’s presence as an important part of Lewisville’s industrial landscape. While the quarterly loss may raise concerns, the company’s revenue expectations align with broader economic growth trends under the current administration’s emphasis on American manufacturing and innovation.
Analysts note that the adjusted earnings figure of 18 cents per share indicates that, after accounting for one‑time expenses, the company remains profitable on an operational basis. This profitability can help sustain jobs and tax revenues that benefit the city.
What’s next: Orthofix will release its fourth‑quarter results later this year, and the company’s full‑year performance will be closely watched by investors and local stakeholders alike.
Sources: wtop.com
